We are committed to solving the problem in the future which with ageing population orthopedic need, we believe the orthopedic relevant medical devices would increase rapidly, and our main purpose is to improve patient’s quality of life, from now till every moment in the future.

The Core competencies of WeMED Bio-Tech :

• Reduce and avoid Radiation Hazards
• Saving surgery time
• Reduce injuries caused by surgery and speed up the recovery of patients
• Reduce the chance of sequelae after surgery
• Use Innovative methods and technologies to surpass many related products on the market.

The need of intramedullary nail would be about 2.4M in 2024. The ceiling of the service available market is about 30% (4 major IM nail players share 80% of the global market) the size of service obtainable market is about USD 450M. If the end user price is set to be USD 300, the annual revenue will be about USD 150~200M for iMET device.

(Reference : Company information)